PRFree
B

bhawnagupta6588

@bhawnagupta6588 · Author · 20 Releases

RSS Feed

Pharmascroll offering Quality Healthcare and Pharmaceutical Market Research services
August 13, 2018
Schizophrenia: Disease Insights & Market Forecasts to 2024 by Pharmascroll
June 12, 2018
Epilepsy: Disease Insights and Market Forecasts to 2024 by Pharmascroll
June 6, 2018
Parkinson’s: Disease Insights and Market Forecasts to 2024 by Pharmascroll
June 4, 2018
Asthma: Disease Insights and Market Forecasts to 2024 by Pharmascroll
May 23, 2018
COPD: Disease Insights and Market Forecasts to 2024 by Pharmascroll
May 21, 2018
Cystic Fibrosis: Disease Insights and Market Forecasts to 2024 by Pharmascroll
May 15, 2018
Alzheimer’s: Disease Insights and Market Forecasts to 2024 by Pharmascroll
May 14, 2018
Pharmascroll launches Market intelligence reports on disease indications
May 8, 2018
Pharmascroll expands its Market Research offerings to multiple Disease Areas
April 4, 2018
SPMS – Pharmascroll Report predicts increase in market activity in next 5-10 years
March 21, 2018
SPMS – Pharmascroll Report predicts increase in market activity in next 5-10 years
March 20, 2018
Pharmascroll launches Quality Focused Pharmaceutical Market Research services at affordable cost
March 14, 2018
Pharmascroll launches operations in Customized Pharmaceutical Marketing Research
March 7, 2018
Pharmascroll, a Research & Consulting Firm, comes up with 30+ reports in multiple indications
February 20, 2018
Pharmascroll Research & Consulting and Market Publishers Ltd Sign Partnership Agreement
February 20, 2018
Secondary Progressive MS – Majority MS patients progress to SPMS indicating huge market potential
February 17, 2018
Anti CGRP molecules to make a paradigm shift in the Migraine treatment landscape
February 17, 2018
Migraine – Launch of new molecules to enhance treatment opportunities
February 11, 2018
Primary Progressive MS – Strong pipeline in progressive MS indicates a paradigm shift
February 11, 2018